最新消息

TAIWAN: TFDA NOTICE: AMENDMENT ON “REGULATIONS GOVERNING THE CLASSIFICATION OF MEDICAL DEVICES”– OCTOBER/NOVEMBER 2023

TAIWAN: TFDA NOTICE: AMENDMENT ON “REGULATIONS GOVERNING THE CLASSIFICATION OF MEDICAL DEVICES”– OCTOBER/NOVEMBER 2023

  • 2023-10-20 06:31:20

Recently, TFDA has announced an amendment to the classifications of medical devices. The scopes and identifications of several medical device classifications have been updated to provide more specific and clearer instructions. Among these, the risk level of 3 classifications has been re-determined and there are 11 new additional classifications.

了解更多
PHILIPPINES: Updated Draft Guidelines for Availing Compassionate Special Permit for the Restricted Use of Unregistered or Unauthorized Drug Products including Vaccines and Medical Devices – March/April 2023

PHILIPPINES: Updated Draft Guidelines for Availing Compassionate Special Permit for the Restricted Use of Unregistered or Unauthorized Drug Products including Vaccines and Medical Devices – March/April 2023

  • 2023-03-27 08:52:43

PFDA presented a draft of the updated guidelines on obtaining a special permit for restricted use of unregistered drug and medical device products. In addition to previous patient conditions laid out by previous regulations, this new guidance widens the product scope to vaccines and the diseases to include those that may result in the patient's permanent disability.

了解更多
THAILAND: Medical Device Categories Applicable for Full CSDT Submission and Partial 2 Submission Route – January/February 2023

THAILAND: Medical Device Categories Applicable for Full CSDT Submission and Partial 2 Submission Route – January/February 2023

  • 2023-01-19 01:28:15

As we are easing into the first quarter of 2023, we are thus simultaneously entering into the last phase of Thai FDA grace period regarding the transition to the risk-classification approach. Thus, Thai FDA has published a summary of the medical device categories on their official website instructing medical device registration via Full CSDT submission and Partial 2 Submission route.

了解更多